SCHEMBL22157017

SCHEMBL22157017

N#Cc1c(-n2c3ccccc3c3ccc(-c4ccccc4)cc32)cc(-c2c(F)c(F)cc(F)c2F)cc1-n1c2ccccc2c2ccc(-c3ccccc3)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 1/20 0.35
PDE1C Q14123 1/20 0.35
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
HTR3A P46098 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KDM4A O75164 1/20 0.31
KDM5B Q9UGL1 1/20 0.31
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31
SQOR Q9Y6N5 1/20 0.31
ACLY P53396 1/20 0.30
GRIA2 P42262 1/20 0.30
GRIA4 P48058 1/20 0.30
FLT3 P36888 1/20 0.30
AKR1A1 P14550 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22155933 0.96 CYP11B1 (0.35) CYP11B1CYP11B2KDM4AKDM5BSMN1; SMN2
SCHEMBL22156467 0.93 PDE9A (0.34) PDE9APDE1CCYP11B1CYP11B2HTR3A
SCHEMBL22157008 0.93 PDE9A (0.35) PDE9APDE1CCYP11B1CYP11B2HTR3A
SCHEMBL22155937 0.93 PDE9A (0.36) PDE9APDE1CCYP11B1CYP11B2HTR3A
SCHEMBL22156472 0.92 PDE9A (0.34) PDE9APDE1CCYP11B1CYP11B2HTR3A
SCHEMBL22158431 0.91 CYP11B1 (0.37) PDE9APDE1CCYP11B1CYP11B2HTR3A
SCHEMBL22157011 0.90 CYP11B1 (0.34) CYP11B1CYP11B2KDM4AKDM5BSMN1; SMN2
SCHEMBL22158409 0.90 PDE9A (0.35) PDE9APDE1CCYP11B1CYP11B2HTR3A
SCHEMBL22155927 0.90 CYP11B1 (0.35) PDE9APDE1CCYP11B1CYP11B2KDM5B
SCHEMBL22155942 0.89 SMN1; SMN2 (0.34) PDE9APDE1CCYP11B1CYP11B2KDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 PDE9A 4546/4885PDE1C 4637/4885CYP11B1 827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.